Security key
48115J109
- Security type / class
- Equity / Common Stock
- Shares outstanding
- 21,352,124
- Total 13F shares
- 11,022,797
- Share change
- +2,437,780
- Total reported value
- $84,985,269
- Reported price per share
- $7.71
- Number of holders
- 76
- Value change
- +$18,818,454
- Number of buys
- 50
- Number of sells
- 20
Security identity
Holder snapshot
Report period
Q4 2025
Institutions
76
Top holders
10
DERM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Ownership snapshot
Top reported holders of DERM - Journey Medical Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
TANG CAPITAL MANAGEMENT LLC
13D/G signal
TANG CAPITAL MANAGEMENT LLC
Evidence rows
15
Latest as of
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 8%
13D/G row: TANG CAPITAL MANAGEMENT LLC
Showing 1-6 of 15 holder rows.
Rank 1 holder
TANG CAPITAL MANAGEMENT LLC
13D/G
13F
- Ownership
- 8%
- Position
- $14.02M
Rank 2 holder
Lindsay A. Rosenwald MD
3/4/5
- Ownership
- 1.8%
- Position
- $2.68M
Rank 3 holder
Justin Adam Smith
3/4/5
- Ownership
- 0.8%
- Position
- $1.19M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
8%
|
$14,020,746
1,854,596 shares
|
$0 | 31 Mar 2025 |
| Lindsay A. Rosenwald MD |
3/4/5
Director
|
1.8%
|
$2,682,302
387,616 shares
|
— | 05 Aug 2025 |
| Justin Adam Smith |
3/4/5
Director
|
0.8%
|
$1,187,596
171,618 shares
|
— | 05 Aug 2025 |
| Miranda Jayne Toledano |
3/4/5
Director
|
0.51%
|
$751,636
108,618 shares
|
— | 05 Aug 2025 |
| Neil Herskowitz |
3/4/5
Director
|
0.51%
|
$751,636
108,618 shares
|
— | 05 Aug 2025 |
| Michael Cooper Pearce |
3/4/5
Director
|
0.27%
|
$395,637
57,173 shares
|
— | 05 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
76
Shares
11,022,797
Rows available
76
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
67
Q4 2025 holders
76
Holder diff
9
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend